These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27031730)

  • 21. Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.
    Vinther-Jensen T; Simonsen AH; Budtz-Jørgensen E; Hjermind LE; Nielsen JE
    Eur J Neurol; 2015 Oct; 22(10):1378-84. PubMed ID: 26073975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluid and imaging biomarkers for Huntington's disease.
    Zeun P; Scahill RI; Tabrizi SJ; Wild EJ
    Mol Cell Neurosci; 2019 Jun; 97():67-80. PubMed ID: 30807825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides are Decreased in Huntington's Disease.
    Al Shweiki MR; Oeckl P; Pachollek A; Steinacker P; Barschke P; Halbgebauer S; Anderl-Straub S; Lewerenz J; Ludolph AC; Bernhard Landwehrmeyer G; Otto M
    Mov Disord; 2021 Feb; 36(2):492-497. PubMed ID: 33006791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleic Acid Therapeutics in Huntington's Disease.
    Singh K; Roy I
    Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
    Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
    Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects.
    Herman S; Niemelä V; Emami Khoonsari P; Sundblom J; Burman J; Landtblom AM; Spjuth O; Nyholm D; Kultima K
    Sci Rep; 2019 Mar; 9(1):4129. PubMed ID: 30858393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease.
    Przybyl L; Wozna-Wysocka M; Kozlowska E; Fiszer A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.
    Jeitner TM; Bogdanov MB; Matson WR; Daikhin Y; Yudkoff M; Folk JE; Steinman L; Browne SE; Beal MF; Blass JP; Cooper AJ
    J Neurochem; 2001 Dec; 79(5):1109-12. PubMed ID: 11739625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.
    Chang KH; Wu YR; Chen YC; Chen CM
    Brain Behav Immun; 2015 Feb; 44():121-7. PubMed ID: 25266150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.
    Constantinescu R; Romer M; Oakes D; Rosengren L; Kieburtz K
    Parkinsonism Relat Disord; 2009 Mar; 15(3):245-8. PubMed ID: 19056308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
    Flament J; Hantraye P; Valette J
    Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI biomarkers in Huntington's disease.
    van den Bogaard S; Dumas E; van der Grond J; van Buchem M; Roos R
    Front Biosci (Elite Ed); 2012 Jan; 4(5):1910-25. PubMed ID: 22202007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease.
    Weiss A; Abramowski D; Bibel M; Bodner R; Chopra V; DiFiglia M; Fox J; Kegel K; Klein C; Grueninger S; Hersch S; Housman D; Régulier E; Rosas HD; Stefani M; Zeitlin S; Bilbe G; Paganetti P
    Anal Biochem; 2009 Dec; 395(1):8-15. PubMed ID: 19664996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.
    Rodrigues FB; Byrne LM; De Vita E; Johnson EB; Hobbs NZ; Thornton JS; Scahill RI; Wild EJ
    Eur J Neurosci; 2019 Jun; 49(12):1632-1639. PubMed ID: 30687961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges of Huntington's disease and quest for therapeutic biomarkers.
    Kotrcova E; Jarkovska K; Valekova I; Zizkova M; Motlik J; Gadher SJ; Kovarova H
    Proteomics Clin Appl; 2015 Feb; 9(1-2):147-58. PubMed ID: 25290828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas.
    Fazio P; Paucar M; Svenningsson P; Varrone A
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):85. PubMed ID: 30291526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Huntington's disease: 4 big questions.
    Nowogrodzki A
    Nature; 2018 May; 557(7707):S48. PubMed ID: 29844555
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of biomarkers for Huntington's disease.
    Weir DW; Sturrock A; Leavitt BR
    Lancet Neurol; 2011 Jun; 10(6):573-90. PubMed ID: 21601164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
    Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
    Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.
    Dalrymple A; Wild EJ; Joubert R; Sathasivam K; Björkqvist M; Petersén A; Jackson GS; Isaacs JD; Kristiansen M; Bates GP; Leavitt BR; Keir G; Ward M; Tabrizi SJ
    J Proteome Res; 2007 Jul; 6(7):2833-40. PubMed ID: 17552550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.